Suicide rates have not slumped under the onslaught of antidepressants, mood-stabilizers, anxiolytic and anti-psychotic drugs; the jump in suicide rates suggests that the opposite is true. In some cases, suicide risk skyrockets once treatment begins (the patient may feel not only penalized for a justifiable reaction, but permanently stigmatized as malfunctioning). Studies show that self-loathing sharply decreases only in the course of cognitive-behavioral treatment.